Does [ KeLuoXin medicated serum extract inhibit high glucose-induced proliferation and phosphorylation of ERK1/2 in rat mesangial cell ]?
KLX can inhibit rat mesangial cell proliferation, and the mechanisms may relate to the interruption of ERK1/2-Mitogen-activated protein kinase (MAPK) pathway.
Within the limitations of this retrospective study, the results suggest that there are risk factors associated with maxillary posterior implant failure. Implants placed in areas with inadequate residual crestal bone height that required sinus augmentation were statistically associated with implant failure.